OREANDA-NEWS. According to the results of the first stage of research, the Sputnik V coronavirus vaccine for children forms good post-vaccination cellular immunity, the press service of the Moscow Mayor reports.

A study of the safety and efficacy of the Sputnik V vaccine for the child population is currently underway in Moscow. The first stage of the study involved 99 minors (56 boys and 43 girls) aged 12-17 years. 92 volunteers received both components of the study vaccine. The volume of the drug administered is 1/10 or 1/5 of the immunizing dose for adults.

"The results of the first stage of the study allow us to draw the following conclusions: double vaccination of volunteers with vaccines of both 1/10 and 1/5 of the immunizing dose, targeted at adults, can lead to the formation of good post-vaccination cellular immunity; the drug has shown a favorable safety and immunogenicity profile; safety and immunogenicity is superior to that in adult participants in a similar phase 1-2 study, "the report says.

Currently, volunteers are being pre-selected for the second stage of the study.

Preliminary selection of volunteers for the second phase of trials of a COVID-19 vaccine for adolescents has begun in Moscow. This was reported by the press service of the mayor and the government of the capital, reports TASS.